Article info
PostScript
Letter
Is HBV RNA a valid marker for predicting sustained viral response for nucleoside analogue cessation?
- Correspondence to Professor Virendra Singh, Hepatology, PGIMER, Chandigarh, Chandigarh, India; virendrasingh100{at}hotmail.com
Citation
Is HBV RNA a valid marker for predicting sustained viral response for nucleoside analogue cessation?
Publication history
- Received October 13, 2020
- Revised October 25, 2020
- Accepted October 27, 2020
- First published November 6, 2020.
Online issue publication
September 08, 2021
Article Versions
- Previous version (6 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.